-
1
-
-
34848844088
-
Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study
-
Costagliola D, Descamps D, Assoumou L, Morand-Joubert L, Marcelin AG, et al. (2007) Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study. J Acquir Immune Defic Syndr 46: 12-18.
-
(2007)
J Acquir Immune Defic Syndr
, vol.46
, pp. 12-18
-
-
Costagliola, D.1
Descamps, D.2
Assoumou, L.3
Morand-Joubert, L.4
Marcelin, A.G.5
-
2
-
-
34147138794
-
Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen
-
Cozzi-Lepri A, Phillips AN, Ruiz L, Clotet B, Loveday C, et al. (2007) Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen. Aids 21: 721-732.
-
(2007)
Aids
, vol.21
, pp. 721-732
-
-
Cozzi-Lepri, A.1
Phillips, A.N.2
Ruiz, L.3
Clotet, B.4
Loveday, C.5
-
3
-
-
3843061223
-
Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy
-
Kantor R, Shafer RW, Follansbee S, Taylor J, Shilane D, et al. (2004) Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy. Aids 18: 1503-1511.
-
(2004)
Aids
, vol.18
, pp. 1503-1511
-
-
Kantor, R.1
Shafer, R.W.2
Follansbee, S.3
Taylor, J.4
Shilane, D.5
-
5
-
-
33847375714
-
Prise en charge médicale des personnes infectées par le VIH
-
du groupe d'experts sous la direction du Pr Yeni, Ministère de la Santé et des Sports
-
Recommandations, du groupe d'experts sous la direction du Pr Yeni (2006) Prise en charge médicale des personnes infectées par le VIH. Ministère de la Santé et des Sports.
-
(2006)
-
-
Recommandations1
-
7
-
-
84871715359
-
-
The European AIDS Clinical Society, Guidelines for treatment of HIV infected adults in Europe. Version 6.0. October 2011; 1-60. Available:
-
The European AIDS Clinical Society (2011) Guidelines for treatment of HIV infected adults in Europe. Version 6.0. October 2011; 1-60. Available: http://www.europeanaidsclinicalsociety.org/images/stories/EACS-Pdf/eacsguidelines-6.pdf.
-
(2011)
-
-
-
8
-
-
77955145227
-
Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations
-
Bansi L, Sabin C, Delpech V, Hill T, Fisher M, et al. (2010) Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations. HIV Med 11: 432-438.
-
(2010)
HIV Med
, vol.11
, pp. 432-438
-
-
Bansi, L.1
Sabin, C.2
Delpech, V.3
Hill, T.4
Fisher, M.5
-
9
-
-
64649101845
-
Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France
-
Chaix ML, Descamps D, Wirden M, Bocket L, Delaugerre C, et al. (2009) Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France. Aids 23: 717-724.
-
(2009)
Aids
, vol.23
, pp. 717-724
-
-
Chaix, M.L.1
Descamps, D.2
Wirden, M.3
Bocket, L.4
Delaugerre, C.5
-
10
-
-
84871715721
-
Trend over calendar time in virological failure in HIV-infected patients treated for at least six months with combined antiretroviral therapy in France (FHDH ANRS CO04)
-
6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention Rome
-
Delaugerre C, Ghosn J, Lacombe J-M, Pialoux G, Cuzin L, et al. (2011) Trend over calendar time in virological failure in HIV-infected patients treated for at least six months with combined antiretroviral therapy in France (FHDH ANRS CO04). 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention Rome.
-
(2011)
-
-
Delaugerre, C.1
Ghosn, J.2
Lacombe, J.-M.3
Pialoux, G.4
Cuzin, L.5
-
11
-
-
2342591920
-
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia
-
Karlsson AC, Younger SR, Martin JN, Grossman Z, Sinclair E, et al. (2004) Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. Aids 18: 981-989.
-
(2004)
Aids
, vol.18
, pp. 981-989
-
-
Karlsson, A.C.1
Younger, S.R.2
Martin, J.N.3
Grossman, Z.4
Sinclair, E.5
-
12
-
-
0032817872
-
Detectable HIV-1 RNA at levels below quantifiable limits by amplicor HIV-1 monitor is associated with virologic relapse on antiretroviral therapy
-
Pilcher CD, Miller WC, Beatty ZA, Eron JJ, (1999) Detectable HIV-1 RNA at levels below quantifiable limits by amplicor HIV-1 monitor is associated with virologic relapse on antiretroviral therapy. Aids 13: 1337-1342.
-
(1999)
Aids
, vol.13
, pp. 1337-1342
-
-
Pilcher, C.D.1
Miller, W.C.2
Beatty, Z.A.3
Eron, J.J.4
-
13
-
-
77956091353
-
Persistent low-level viremia is associated with increased risk of virologic failure and mortality
-
San Francisco
-
Hull M, Loufty M, Zhang W, Shen A, Druyts E, et al. (2010) Persistent low-level viremia is associated with increased risk of virologic failure and mortality. San Francisco.
-
(2010)
-
-
Hull, M.1
Loufty, M.2
Zhang, W.3
Shen, A.4
Druyts, E.5
-
14
-
-
84871720601
-
-
Assoumou L, Descamps D, Yerly S, Dos Santos G, Marcelin AG, et al. (2010) Prevalence of HIV-1 drug resistance in treated patients with viral load>50 copies/ml in 2009: a French nationwide study; International HIV Drug Resistance Workshop Dubrovnik.
-
(2010)
Prevalence of HIV-1 Drug Resistance in Treated Patients with Viral Load>50 Copies/Ml in 2009: A French Nationwide Study; International HIV Drug Resistance Workshop Dubrovnik
-
-
Assoumou, L.1
Descamps, D.2
Yerly, S.3
Dos Santos, G.4
Marcelin, A.G.5
-
15
-
-
84871722130
-
-
Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. January 10, 2011; 1-166. Available:
-
Department of Health and Human Services (2011) Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. January 10, 2011; 1-166. Available: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
-
(2011)
-
-
-
16
-
-
2942618578
-
The lymphocyte HIV reservoir in patients on long-term HAART is a memory of virus evolution
-
Lambotte O, Chaix ML, Gubler B, Nasreddine N, Wallon C, et al. (2004) The lymphocyte HIV reservoir in patients on long-term HAART is a memory of virus evolution. Aids 18: 1147-1158.
-
(2004)
Aids
, vol.18
, pp. 1147-1158
-
-
Lambotte, O.1
Chaix, M.L.2
Gubler, B.3
Nasreddine, N.4
Wallon, C.5
-
17
-
-
84555206693
-
Incidence of HIV-1 Drug Resistance Among Antiretroviral Treatment-Naive Individuals Starting Modern Therapy Combinations
-
Clin Infect Dis
-
von Wyl V, Yerly S, Boni J, Shah C, Cellerai C, et al. (2011) Incidence of HIV-1 Drug Resistance Among Antiretroviral Treatment-Naive Individuals Starting Modern Therapy Combinations. Clin Infect Dis.
-
(2011)
-
-
von Wyl, V.1
Yerly, S.2
Boni, J.3
Shah, C.4
Cellerai, C.5
-
18
-
-
9144271024
-
Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine
-
Kempf DJ, King MS, Bernstein B, Cernohous P, Bauer E, et al. (2004) Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine. J Infect Dis 189: 51-60.
-
(2004)
J Infect Dis
, vol.189
, pp. 51-60
-
-
Kempf, D.J.1
King, M.S.2
Bernstein, B.3
Cernohous, P.4
Bauer, E.5
-
19
-
-
20444430423
-
Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavir
-
King MS, Brun SC, Kempf DJ, (2005) Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavir. J Infect Dis 191: 2046-2052.
-
(2005)
J Infect Dis
, vol.191
, pp. 2046-2052
-
-
King, M.S.1
Brun, S.C.2
Kempf, D.J.3
-
20
-
-
80052897871
-
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results
-
Sax PE, Tierney C, Collier AC, Daar ES, Mollan K, et al. (2011) Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results. J Infect Dis 204: 1191-1201.
-
(2011)
J Infect Dis
, vol.204
, pp. 1191-1201
-
-
Sax, P.E.1
Tierney, C.2
Collier, A.C.3
Daar, E.S.4
Mollan, K.5
-
21
-
-
33747689078
-
Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy
-
Sungkanuparph S, Groger RK, Overton ET, Fraser VJ, Powderly WG, (2006) Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy. HIV Med 7: 437-441.
-
(2006)
HIV Med
, vol.7
, pp. 437-441
-
-
Sungkanuparph, S.1
Groger, R.K.2
Overton, E.T.3
Fraser, V.J.4
Powderly, W.G.5
-
22
-
-
79960877415
-
Antiretroviral Drug Resistance in HIV-1-Infected Patients Experiencing Persistent Low-Level Viremia During First-Line Therapy
-
Taiwo B, Gallien S, Aga E, Ribaudo H, Haubrich R, et al. (2011) Antiretroviral Drug Resistance in HIV-1-Infected Patients Experiencing Persistent Low-Level Viremia During First-Line Therapy. J Infect Dis 204: 515-520.
-
(2011)
J Infect Dis
, vol.204
, pp. 515-520
-
-
Taiwo, B.1
Gallien, S.2
Aga, E.3
Ribaudo, H.4
Haubrich, R.5
-
23
-
-
79952443361
-
Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia
-
Gallien S, Delaugerre C, Charreau I, Braun J, Boulet T, et al. (2011) Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia. Aids 25: 665-669.
-
(2011)
Aids
, vol.25
, pp. 665-669
-
-
Gallien, S.1
Delaugerre, C.2
Charreau, I.3
Braun, J.4
Boulet, T.5
-
24
-
-
77953263347
-
Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients
-
Caby F, Valin N, Marcelin AG, Schneider L, Andrade R, et al. (2010) Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients. Scand J Infect Dis 42: 527-532.
-
(2010)
Scand J Infect Dis
, vol.42
, pp. 527-532
-
-
Caby, F.1
Valin, N.2
Marcelin, A.G.3
Schneider, L.4
Andrade, R.5
-
25
-
-
78349304726
-
Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen
-
Charpentier C, Roquebert B, Colin C, Taburet AM, Fagard C, et al. (2010) Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen. Aids 24: 2651-2656.
-
(2010)
Aids
, vol.24
, pp. 2651-2656
-
-
Charpentier, C.1
Roquebert, B.2
Colin, C.3
Taburet, A.M.4
Fagard, C.5
|